Immunogen reported $-37339000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Amgen AMGN:US $ 1884M 1420M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Astellas Pharma 4503:JP Y 40923M 10237M
AstraZeneca AZN:LN -1652M 2202M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Bristol Myers Squibb BMY:US $ 1546M 491M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Dicerna Pharmaceuticals DRNA:US $ -17.07M 23.74M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Emergent Biosolutions EBS:US $ -32.7M 37.3M
Exelixis EXEL:US $ 38.2M 57.89M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Immunogen IMGN:US $ -37.34M 6.6M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Macrogenics MGNX:US $ -52.89M 12.95M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Novartis NVS:US $ 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Seattle Genetics SGEN:US $ -293.85M 209.27M